Epiomic Epidemiology Series: Alzheimer's Disease Forecast in 12 Major Markets 2017-2027

Tuesday, April 11, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, April 11, 2017 /PRNewswire/ -- Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Alzheimer's disease in 12 Major Markets

Alzheimer's disease (AD) is a progressive, irreversible neurodegenerative disorder. It is the leading cause of dementia. Alzheimer's is associated with the increase of beta amyloid and tau proteins in the brains of affected patients. Read the
full report: http://www.reportlinker.com/p04756185/Epiomic-Epidemiology-Series-Alzheimer-s-Disease-Forecast-in-12-Major-Markets.htmlCognitive function declines and patients suffer memory loss and disorientation amongst many other neuropsychiatric conditions as the disease progresses. This report provides the current prevalent population for Alzheimer's disease across 12 Major Markets (USA, Canada, France, Germany, Russia, Italy, Spain, UK, Brazil, Japan, India and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity. Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Alzheimer's have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Alzheimer's disease include: - Other dementias - Depression and other psychiatric conditions - Hypertension - Diabetes - Glaucoma - Osteoporosis and osteopenia - Education level / years of education This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report. Reason to buy - Able to quantify patient populations in global Alzheimer's disease's market to target the development of future products, pricing strategies and launch plans. - Gain further insight into the prevalence of the subdivided types of Alzheimer's disease and identify patient segments with high potential. - Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries. - Provide a level of understanding on the impact from specific co-morbid conditions on Alzheimer's disease's prevalent population. - Identify sub-populations within Alzheimer's disease which require treatment. - Gain an understanding of the specific markets that have the largest number of Alzheimer's disease patients. Read the full report: http://www.reportlinker.com/p04756185/Epiomic-Epidemiology-Series-Alzheimer-s-Disease-Forecast-in-12-Major-Markets.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/epiomic-epidemiology-series-alzheimers-disease-forecast-in-12-major-markets-2017-2027-300438145.html

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store